JOHN LYDON to Breast Neoplasms
This is a "connection" page, showing publications JOHN LYDON has written about Breast Neoplasms.
Connection Strength
0.742
-
A Novel Effect of ?-Adrenergic Receptor on Mammary Branching Morphogenesis and its Possible Implications in Breast Cancer. J Mammary Gland Biol Neoplasia. 2017 03; 22(1):43-57.
Score: 0.214
-
From the ranks of mammary progesterone mediators, RANKL takes the spotlight. Mol Cell Endocrinol. 2012 Jun 24; 357(1-2):91-100.
Score: 0.148
-
Minireview: steroid receptor coactivator-3: a multifarious coregulator in mammary gland metastasis. Endocrinology. 2011 Jan; 152(1):19-25.
Score: 0.139
-
Progesterone receptors in mammary gland development and tumorigenesis. J Mammary Gland Biol Neoplasia. 2003 Apr; 8(2):205-14.
Score: 0.082
-
Pathway-centric integrative analysis identifies RRM2 as a prognostic marker in breast cancer associated with poor survival and tamoxifen resistance. Neoplasia. 2014 May; 16(5):390-402.
Score: 0.044
-
Stem cells: Cues from steroid hormones. Nature. 2010 Jun 10; 465(7299):695-6.
Score: 0.034
-
Progesterone-dependent regulation of female reproductive activity by two distinct progesterone receptor isoforms. Steroids. 2003 Nov; 68(10-13):771-8.
Score: 0.021
-
Progesterone involvement in breast development and tumorigenesis--as revealed by progesterone receptor "knockout" and "knockin" mouse models. Steroids. 2003 Nov; 68(10-13):779-87.
Score: 0.021
-
Targeting progesterone signaling prevents metastatic ovarian cancer. Proc Natl Acad Sci U S A. 2020 12 15; 117(50):31993-32004.
Score: 0.018
-
Application of 13C isotope labeling using liquid chromatography mass spectrometry (LC-MS) to determining phosphate-containing metabolic incorporation. J Mass Spectrom. 2013 Dec; 48(12):1270-5.
Score: 0.011
-
Estrogen-regulated prohibitin is required for mouse uterine development and adult function. Endocrinology. 2011 Mar; 152(3):1047-56.
Score: 0.009